Mantle Cell Lymphoma

Ultima Vez Modificado: 28 de septiembre del 2006

Translation for this article does not exist


Where Are the Adults in the Room?
by Rodney Warner, JD
November 20, 2015

Related News

FDA Approves Imbruvica for Mantle Cell Lymphoma

Nov 14, 2013

Drug designed to inhibit enzyme that cancer cells need to spread; granted "breakthrough therapy" status

Ibrutinib Active in Refractory or Relapsed Mantle-Cell Lymphoma

Jun 20, 2013

Response rate of 68 percent; estimated rate of overall survival, 58 percent at 18 months

R-CHOP Benefits Older Mantle-Cell Lymphoma Patients

Aug 9, 2012

Improved survival for older patients with R-CHOP induction, rituximab maintenance treatment